206 related articles for article (PubMed ID: 27807478)
21. Tumour-associated mutant p53 drives the Warburg effect.
Zhang C; Liu J; Liang Y; Wu R; Zhao Y; Hong X; Lin M; Yu H; Liu L; Levine AJ; Hu W; Feng Z
Nat Commun; 2013; 4():2935. PubMed ID: 24343302
[TBL] [Abstract][Full Text] [Related]
22. [Direct interaction between BAG5 protein and Parkin protein].
Wang X; Guo J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1156-61. PubMed ID: 21131737
[TBL] [Abstract][Full Text] [Related]
23. The interplay between mutant p53 and the mevalonate pathway.
Parrales A; Thoenen E; Iwakuma T
Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
[TBL] [Abstract][Full Text] [Related]
24. Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy.
He C; Li L; Guan X; Xiong L; Miao X
Chemotherapy; 2017; 62(1):43-53. PubMed ID: 27322648
[TBL] [Abstract][Full Text] [Related]
25. Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival.
Foggetti G; Ottaggio L; Russo D; Mazzitelli C; Monti P; Degan P; Miele M; Fronza G; Menichini P
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30745455
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation.
Chen X; Zhang T; Su W; Dou Z; Zhao D; Jin X; Lei H; Wang J; Xie X; Cheng B; Li Q; Zhang H; Di C
Cell Death Dis; 2022 Nov; 13(11):974. PubMed ID: 36400749
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.
Bruchmann A; Roller C; Walther TV; Schäfer G; Lehmusvaara S; Visakorpi T; Klocker H; Cato AC; Maddalo D
BMC Cancer; 2013 Mar; 13():96. PubMed ID: 23448667
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
[TBL] [Abstract][Full Text] [Related]
29. Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch.
Bracho-Valdés I; Cervantes-Villagrana RD; Beltrán-Navarro YM; Olguín-Olguín A; Escobar-Islas E; Carretero-Ortega J; Olivares-Reyes JA; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139359
[TBL] [Abstract][Full Text] [Related]
30. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.
Alexandrova EM; Yallowitz AR; Li D; Xu S; Schulz R; Proia DA; Lozano G; Dobbelstein M; Moll UM
Nature; 2015 Jul; 523(7560):352-6. PubMed ID: 26009011
[TBL] [Abstract][Full Text] [Related]
31. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
Kalia SK; Lee S; Smith PD; Liu L; Crocker SJ; Thorarinsdottir TE; Glover JR; Fon EA; Park DS; Lozano AM
Neuron; 2004 Dec; 44(6):931-45. PubMed ID: 15603737
[TBL] [Abstract][Full Text] [Related]
32. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
33. Gambogic acid counteracts mutant p53 stability by inducing autophagy.
Foggetti G; Ottaggio L; Russo D; Monti P; Degan P; Fronza G; Menichini P
Biochim Biophys Acta Mol Cell Res; 2017 Feb; 1864(2):382-392. PubMed ID: 27899303
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the vitamin D3 response by cancer-associated mutant p53.
Stambolsky P; Tabach Y; Fontemaggi G; Weisz L; Maor-Aloni R; Siegfried Z; Shiff I; Kogan I; Shay M; Kalo E; Blandino G; Simon I; Oren M; Rotter V
Cancer Cell; 2010 Mar; 17(3):273-85. PubMed ID: 20227041
[TBL] [Abstract][Full Text] [Related]
36. Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.
Mukherjee S; Maddalena M; Lü Y; Martinez S; Nataraj NB; Noronha A; Sinha S; Teng K; Cohen-Kaplan V; Ziv T; Arandkar S; Hassin O; Chatterjee R; Pirona AC; Shreberk-Shaked M; Gershoni A; Aylon Y; Elazar Z; Yarden Y; Schramek D; Oren M
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2119644119. PubMed ID: 35439056
[TBL] [Abstract][Full Text] [Related]
37. BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.
Friesen EL; Zhang YT; Earnshaw R; De Snoo ML; O'Hara DM; Agapova V; Chau H; Ngana S; Chen KS; Kalia LV; Kalia SK
Front Cell Dev Biol; 2020; 8():716. PubMed ID: 32850835
[TBL] [Abstract][Full Text] [Related]
38. Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.
Zhang Y; Hu Y; Fang JY; Xu J
Oncotarget; 2016 Mar; 7(10):11056-66. PubMed ID: 26840456
[TBL] [Abstract][Full Text] [Related]
39. Mutant p53 in Cancer Progression and Targeted Therapies.
Zhu G; Pan C; Bei JX; Li B; Liang C; Xu Y; Fu X
Front Oncol; 2020; 10():595187. PubMed ID: 33240819
[No Abstract] [Full Text] [Related]
40. Crizotinib Nanomicelles Synergize with Chemotherapy through Inducing Proteasomal Degradation of Mutp53 Proteins.
Yi T; Qian J; Ye Y; Zhang H; Jin X; Wang M; Yang Z; Zhang W; Wen L; Zhang Y
ACS Appl Mater Interfaces; 2023 Jan; 15(1):511-523. PubMed ID: 36578131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
